# US 2015/0105547 A1 · Nitric oxide releasing steroids

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2015/0105547 A1
- Document ID: US20150105547A1
- Status: Published application
- Kind: A1
- Application number: 14/554,830
- Filed: 2014-11-26
- Published: 2015-04-16
- Earliest claimed: 2007-02-05
- Assignees: Nicox S.A.
- Applicants: Nicox SA
- Inventors: Francesca BENEDINI; Stefano BIONDI; Ennio ONGINI
- Web page: https://patentgrep.com/patent/US20150105547A1

## CPC

- C07J 41/005: {the 17-beta position being substituted by an uninterrupted chain of only two carbon atoms, e.g. pregnane derivatives}
- A61P 1/02: Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A61P 1/04: for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A61P 3/10: for hyperglycaemia, e.g. antidiabetics
- A61P 5/00: Drugs for disorders of the endocrine system
- A61P 5/44: Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids
- A61P 9/00: Drugs for disorders of the cardiovascular system
- A61P 9/10: for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A61P 9/12: Antihypertensives
- A61P 9/14: Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
- A61P 11/00: Drugs for disorders of the respiratory system
- A61P 11/06: Antiasthmatics
- A61P 17/00: Drugs for dermatological disorders
- A61P 17/02: for treating wounds, ulcers, burns, scars, keloids, or the like
- A61P 17/04: Antipruritics
- A61P 17/06: Antipsoriatics
- A61P 17/08: Antiseborrheics
- A61P 17/12: Keratolytics, e.g. wart or anti-corn preparations
- A61P 19/02: for joint disorders, e.g. arthritis, arthrosis
- A61P 27/00: Drugs for disorders of the senses
- A61P 27/02: Ophthalmic agents
- A61P 27/06: Antiglaucoma agents or miotics
- A61P 29/00: Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P 35/00: Antineoplastic agents
- C07J: STEROIDS (seco-steroids C07C)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The invention relates to nitrooxyderivative of corticosteroids of general formula (I) and pharmaceutically acceptable salts or stereoisomers thereof R—(Z)a—Rx (I) wherein R is the corticosteroid residue of formula (II): wherein: R1 is OH, R2 —CH3, or R1 and R2 are taken together to form a group of formula (III) R3 is Cl or F; R4 is H or F; wherein R1, R2, R3 and R4 can be linked to the correspondent carbon atoms of the steroidal structure in position α or β; with the proviso that: when R1 and R2 are the group of formula (III) then R3 is F and R4 is H or F; The compounds are useful in the treatment of respiratory diseases, inflammatory diseases, dermatological diseases and ocular diseases.

## Claims

### Claim 1

A compound of general formula (I) and pharmaceutically acceptable salts or stereoisomers thereof
R—(Z)a—Rx (I)
wherein R is a corticosteroid residue of formula (II):
wherein:
R1 is OH, R2 —CH3, or R1 and R2 are taken together to form a group of formula (III)
R3 is CI or F;
R4 is H or F;
wherein R1, R2, R3 and R4 can be linked to the correspondent carbon atoms of the steroidal structure in position α or β;
with the proviso that:
when R1 and R2 are the group of formula (III) then R3 is F and R4 is H or F;
when R1 is OH and R2 —CH3 then R4 is H and R3 is CI or F;
preferred corticosteroid radicals are R of formula (II) wherein:
R1 is OH in position α, R2 —CH3 in position β, R3 is CI in position α and R4 is H; or
R1 is OH in position α, R2 —CH3 in position β, R3 is F in position α and R4 is H; or
R1 and R2 are taken together to form a group of formula (III)
R3 is F and R4 is H, R1, R2 and R3 are in position α; or
R1 and R2 are taken together to form a group of formula (III)
R3 and R4 are F, R1, R2, R3 and R4 are in position α;
a in formula (I) is equal to 0 or 1;
Z is a group capable of binding Rx and is selected from —C(O)—, or CH(R′)—O— wherein R′ is selected from H or a straight or branched C1-C4 alkyl;
Rx is a radical and is selected from the the following meanings:
A)
—HN—CH(R1)—C(O)-(T-Y—ONO2) (a1)
—C(O)—CH(R1)—NH-(T′-Y—ONO2) (a2)
—HN—CH(R1a-T″-Y′—ONO2)—COOR3a (a3)
—C(O)—CH(R1a-T″-Y′—ONO2)—NHR4a (a4)
—R1b—CH(NHR4a—C(O)-(T-Y—ONO2) (a5)
—R1b—CH(COOR3a)NH-(T′-Y—ONO2) (a6)
—HN—CH(R1a-T″-Y′—ONO2)—C(O)-(T-Y—ONO2) (a7)
—C(O)—CH(R1a-T″-Y′—ONO2)—NH-(T′-Y—ONO2) (a8)
—R1b—CH(NH-T′-Y′—ONO2)—C(O)-(T-Y—ONO2) (a9)
wherein:
R1 is selected from:
A1) H, —CH3, isopropyl, isobutyl, sec-butyl, tert-butyl, methylthio-(CH2)2—, phenyl, benzyl, C6H5—CH2—CH2—, 2-monosubstituted benzyl, or 3-monosubstituted benzyl or 4-monosubstituted benzyl wherein the substituent of the benzyl is selected from —F, —Cl, —I, —NO2, —CF3, —CH3, CN, C6H5CO—; 2,4-dichlorobenzyl, 3,4-dichlorobenzyl, 3,4-difluorobenzyl, 2-pyrrolidyl, 3-triptophanyl-CH2—, 3-benzothienyl-CH2—, 4-imidazolyl-CH2—, 9-anthranyl-CH2—, cyclohexyl, cyclohexyl-CH2—, cyclohexyl-(CH2)2—, cyclopentyl-CH2—, (C6H5)2CH—, 4-B(OH)2-benzyl, 4-quinolyl-CH2—, 3-quinolyl-CH2—, 2-quinolyl-CH2—, 2-quinoxalyl-CH2—, 2-furyl-CH2—, 1-naphtyl-CH2—, 2-naphtyl-CH2—, 2-pyridyl-CH2—, 3-pyridyl-CH2—, 4-pyridyl-CH2—, 2-thienyl-CH2—, 3-thienyl-CH2—, C6H4—CH═CH—CH2—, CH2═CH—CH2—, CH≡CH—CH2—, NH2—CO—CH2—, NH2—CO—(CH2)2—, NH2(═NH)NH—(CH2)3—, P(═O)(OCH3)2, I—CH2—;
A2) —CH2—SH, —CH2—OH, —CH(CH3)—OH, —CH2[(C6H4)-(4-OH)], —CH2-[(C6H2)-(3,5-diiodo)-(4-OH)], —CH2-[(C6H3)-(3-nitro)-(4-OH)];
A3) —CH2—NHR″, —(CH2)2—NHR″, —(CH2)3—NHR″, —(CH2)4—NHR″, wherein R″ is H, —C(O)CH3 or
wherein R5a is H or a linear or branched C1-C10 alkyl chain, preferably R5a is H or a linear (C1-C5) alkyl, wherein R″ is as above defined;
A4) —CH2—C(O)R′″, —(CH2)2—C(O)R′″, —(CH2)4—C(O)R′″ wherein R′″ is —OR5a or
wherein R5a is as above defined, wherein R′″ is as above defined;
R1a is selected from,
A5) —CH2—S—, —CH2—O—, —CH(CH3)—O—, —CH2[(C6H4)-(4-O)], —CH2-[(3,5-diiodo)-(C6H2)-(4-O)], —CH2-[(3-nitro)-(C6H3)-(4-O)—];
A6) —CH2—NH—, —(CH2)2—NH—, —(CH2)3—NH—, —(CH2)4—NH—;
A7) —CH2—C(O)—, —(CH2)2—C(O)—, —(CH2)4—C(O)—;
R3a is selected from H, —R5a or
wherein R5a is as above defined;
R4a is selected from H or —C(O)CH3 or
wherein R5a is as above defined;
R1b is selected from
A8) —S—CH2—, —O—CH(CH3)—, —O—CH2—, [-(4-O)—(C6H4)]—CH2—, [-(4-O)-(3,5-diiodo)-(C6H2)]—CH2—, [-(4-O)-(3-nitro)-(C6H3)]—CH2—;
A9) —HN—CH2—, —HN—(CH2)2—, —HN—(CH2)3—, —HN—(CH2)4—;
A10) —C(O)—CH2—, —C(O)—(CH2)2—, —C(O)—(CH2)4—;
T is selected from —O—, —S—, —NR′—, O—CH(R′)—O—C(O)— or O—CH(R′)—O—C(O)O— wherein R′ is as above defined;
T′ is C(O)—, —C(O)—X″— wherein X″ is —O— or —S—, or T′ is C(O)—NR′— wherein R′ is as above defined;
T″ is independently selected from C(O)—, —C(O)—X″—, —C(O)—NR′—, —O—, —S—, —NR′—, O—CH(R′)—O—C(O)—, O—CH(R′)—O—C(O)O—, wherein X″ and R′ are as above defined, with the proviso that T″ is —C(O)—, —C(O)—X″— or C(O)—NR′— when T″ is linked to —NH—, —O—, or —S—; or
T″ is —O—, —S—, —NR′—, —O—CH(R′)—O—C(O)—, —O—CH(R′)—O—C(O)O— when T″ is linked to C(O)—;
Y and Y′ are as below defined;
B)
—HN—CH(R2)—CH2C(O)-(T-Y—ONO2) (b1)
—C(O)—CH2—CH(R2)—NH-(T-Y—ONO2) (b2)
—HN—CH(R2a-T″-Y—ONO2)—CH2COOR3a (b3)
—C(O)—CH2—CH(R2a-T″-Y—ONO2)—NHR4a (b4)
—R2b—CH(NHR4a—CH2C(O)-(T-Y—ONO2) (b5)
—R2b—CH(CH2COOR3a)NH-(T′-Y—ONO2) (b6)
—HN—CH(R2a-T″-Y′—ONO2)—CH2—C(O)-(T-Y—ONO2) (b7)
—C(O)—CH2—CH(R2a-T″-Y′—ONO2)—NH-(T′-Y—ONO2) (b8)
—R2b—CH(NH-T′-Y′—ONO2)—CH2C(O)-(T-Y—ONO2) (b9)
—R2b—CH(CH2C(O)-T-Y′—ONO2)—NH-(T′-Y—ONO2) (b10)
wherein
R2 is selected from
B1) H, —CH3, CF3, isopropyl, isobutyl, sec-butyl, methylthio-(CH2)2—, phenyl, benzyl, 3-triptophanyl-CH2—, NH2—C(O)—CH2—, NH2—C(O)—(CH2)2—, NH2(═NH)NH—(CH2)3—, tBuO—CH(CH3)—, benzyl-O—CH2—, 4-terbutoxy-benzyl, 4-phenylbenzyl;
B2) —CH2—SH, —CH2—OH, —CH(CH3)—OH, —CH2[(C6H4)-(4-O)—], —CH2-[(C6H2)-(3,5-diiodo)-(4-OH)], —CH2-[(C6H3)-(3-nitro)-(4-OH)];
B3) —CH2—NHR″, —(CH2)2—NHR″, —(CH2)3—NHR″, —(CH2)4—NHR″, wherein R″ is as above defined;
B4) —CH2—C(O)—R′″, —(CH2)2—C(O)—R′″, —(CH2)4—C(O)—R′″ wherein R′″ is as above defined;
R2a is selected from
B5) —CH2—S—, —CH2—O—, —CH(CH3)—O— or —CH2[(C6H4)-(4-O)], —CH2-[(3,5-diiodo)-(C6H2)-(4-O)], —CH2-[(3-nitro)-(C6H3)-(4-O)—];
B6) —CH2—NH—, —(CH2)2—NH—, —(CH2)3—NH—, —(CH2)4—NH—;
B7) —CH2—C(O)—, —(CH2)2—C(O)—, —(CH2)4—C(O);
R2b is selected from
B8) —S—CH2—, —O—CH(CH3)—, —O—CH2—, [-(4-O)—(C6H4)]—CH2—, [-(4-O)-(3,5-diiodo)-(C6H2)]—CH2—, [-(4-O)-(3-nitro)-(C6H3)]—CH2—;
B9) —HN—CH2—, —HN—(CH2)2—, —HN—(CH2)3—, —HN—(CH2)4—;
B10) —C(O)—CH2—, —C(O)—(CH2)2—, —C(O)—(CH2)4—;
R3a and R4a are as above defined;
T, T′ and T″ are as above defined and Y and Y′ are as below defined;
C)
—HN(CH2)b—C(O)-(T-Y—ONO2); (c1)
—C(O)(CH2)b—NH-(T′-Y—ONO2); (c2)
wherein b is an integer from 3 to 6,
T and T′ are as above defined;
D)
—HN—CH(R12)—CH2—O-(T′″-Y—ONO2) (d1)
—O—CH2—CH(R12)—NH-(T′-Y—ONO2) (d2)
—HN—CH(R12a-T″-Y′—ONO2)—CH2OH (d3)
—O—CH2—CH(R12a-T″-Y′—ONO2)—NHR4a (d4)
—R12b—CH(NHR4a)—CH2—O-(T′″-Y—ONO2) (d5)
—R12b—CH(CH2OH)—NH-(T′-Y—ONO2) (d6)
—HN—CH(R12a-T″-Y′—ONO2)—CH2—O-(T′″-Y—ONO2) (d7)
—O—CH2—CH(R12a-T″-Y′—ONO2)—NH-(T′-Y—ONO2) (d8)
—R12b—CH(NH-T′-Y′—ONO2)—CH2—O-(T′″-Y—ONO2) (d9)
—R12b—CH(CH2—O-T′″-Y′—ONO2)—NH-(T′-Y—ONO2) (d10)
wherein
T′″ is independently selected from —C(O)—, —C(O)X″— wherein X″ is —O— or S—, or —C(O)—NR′—
wherein R′ is as above defined;
T′ and T″ are as above defined;
Y and Y′ are as below defined;
R12 is selected from:
D1) H, —CH3, isopropyl, isobutyl, sec-butyl, methylthio-(CH2)2—, benzyl, 3-triptophanyl-CH2—, 4-imidazolyl-CH2—, NH2—CO—CH2—, NH2—CO—(CH2)2—, NH2(═NH)NH—(CH2)3—;
D2) —CH2—OH, —CH(CH3)—OH, CH2[(C6H4)-(4-OH)], CH2-[(C6H3)-(3,5-diiodo)-(4-OH)], —CH2-[(C6H3)-(3-nitro)-(4-ON;
D3) —CH2—NHR″, —(CH2)2—NHR″, —(CH2)3—NHR″, —(CH2)4—NHR″, wherein R″ is as above defined, preferably Ru is —(CH2)4—NHR″;
D4) —CH2—C(O)R′″, —(CH2)2—C(O)R′″, —(CH2)4—C(O)R′″ wherein R′″ is as above defined;
R12a is selected from
D5) —CH2—O—, —CH(CH3)—O— or CH2[(C6H4)-(4-O)], —CH2-[3,5-diiodo-(C6H2)-(4-O)], —CH2-[3-nitro-(C6H3)-4-O-];
D6) —CH2—NH—, —(CH2)2—NH—, —(CH2)3—NH—, —(CH2)4—NH—;
D7) —CH2—C(O)—, —(CH2)2—C(O)—, —(CH2)4—C(O)—;
R12b is selected from
D8) —O—CH2—, —O—CH(CH3)—, [-(4-O)—(C6H4)]—CH2—, [-(4-O)-(3,5-diiodo)-(C6H2)]—CH2, [-(4-O)-(3-nitro)-(C6H3)]—CH2—;
D9) —HN—CH2—, —HN—(CH2)2—, —HN—(CH2)3—, —HN—(CH2)4—;
D10) —C(O)—CH2—, —C(O)—(CH2)2—, —C(O)—(CH2)4—;
R4a is as above defined;
wherein c is equal to 0 or 1, d is an integer from 0 to 3 with the proviso that c is 0 or 1 when d is 0 and c is 0 when d is 1, 2 or 3, T and T′ are as above defined;
wherein e and f are equal to 0 or 1, with the proviso that f is 0 when e is 0 and f is 0 or 1 when e is 1,
T and T′ are as above defined;
wherein R3 is H, CH3, propyl, (C6H5)2CH—, 1-naphtyl-CH2—, benzyl, allyl, 2-bromobenzyl, 2-chlorobenzyl, 3-chlorobenzyl, 4-fluorobenzyl, 4-bromobenzyl, 4-methylbenzyl, T and T′ are as above defined;
wherein R4 is H, benzyl, 4-bromobenzyl, 2-bromobenzyl, T and T′ are as above defined;
wherein R5 is H, R6 is H, or R5 and R6 when taken together are a double bond, T and T′ are as above defined;
wherein T and T′ are as above defined;
wherein T and T′ are as above defined;
wherein c is as above defined, d is equal to 0 or 1, T and T′ are as above defined;
wherein R7 is H, R8 is H, or R7 and R8 when taken together are a double bond, c is as above defined, T and T′ are as above defined;
wherein T and T′ are as above defined;
wherein T and T′ are as above defined and;
wherein T and T′ are as above defined;
wherein T and T′ are as above defined;
wherein T and T′ are as above defined;
wherein R9 and R19 are H, CH3, R11 is CH3 or 4-piperidinyl with the proviso that R9 and R19 are H when R11 is 4-piperidinyl and R9 and R19 are CH3 when R11 is CH3, T and T′ are as above defined;
wherein T and T′ are as above defined;
with the proviso that in the formula (I):
a is 0 or a is 1 and Z is CH(R)—O— wherein R′ is as above defined, when Rx is:
(a2), (a4) or (a8);
(a5), (a6), (a9) or (a10) and R1b is selected from the group A10);
(b2), (b4) or (b8);
(b5), (b6), (b9) or (b10) and R2b is selected from the group B10);
(c2);
(d5), (d6), (d9) or (d10) and R12b is selected from the group D10);
(e2), (f1), (g2), (h1), (i1) (l2), (m2), (n2), (o2), (p2), (q2), (r2), (s2), (t1) or (u2);
a is 1 and Z is —C(O)—, when Rx is:
(a1), (a3) or (a7);
(a5), (a6), (a9) or (a10) and R1b is selected from the groups A8) and A9);
(b1), (b3) or (b7);
(b5), (b6), (b9) or (b10) and R2b is selected from the groups B8) or B9);
(c1);
(d1), (d2), (d3), (d4), (d7) or (d8);
(d5), (d6), (d9) or (d10) and R2b is selected from the groups D8) or D9);
(e1), (f2), (g1), (h2), (i2), (11), (m1), (n1), (o1), (p1), (q1), (r1), (s1), (t2) or (u1).
Y and Y′ are bivalent radicals each independently selected from the following meanings:
a)
straight or branched C1-C20 alkylene;
straight or branched C1-C20 alkylene substituted with one or more of the substituents selected from the group consisting of: halogen atoms, hydroxy, —ONO2 or T2, wherein T2 is —OC(O)(C1-C10 alkyl)-ONO2 or —O(C1-C10 alkyl)-ONO2;
cycloalkylene with 5 to 7 carbon atoms into cycloalkylene ring, the ring being optionally substituted with one or more straight or branched C1-C10 alkyl chains;
wherein
n0 is an integer from 0 to 20;
n1 is 0 or 1;
U is a linear or branched C1-C20 alkylene optionally substituted with a —ONO2 group;
wherein
n0 is an integer from 0 to 20;
n1 is 0 or 1;
U is a linear or branched C1-C20 alkylene optionally substituted with a —ONO2 group;
wherein:
n2 is an integer from 0 to 2, R13 is H or CH3, T1 is —O—C(O)— or —C(O)O—;
n1 and U are as above defined;
n2 is an integer from 0 to 2;
R13 is H or CH3;
Y1 is CH2—CH2— or —CH═CH—(CH2)n2′—, wherein n2′ is 0 or 1;
T1=—O—C(O)— or C(O)O—;
U is a linear or branched C1-C20 alkylene optionally substituted with a —ONO2 group;
wherein:
n2 is an integer from 0 to 2, preferably n2 is 1;
R13 is H or CH3, preferably R13 is CH3;
Y1 is —CH2—CH2— or (CH2)n2′—CH═CH—, wherein n2′ is 0 or 1;
(T1)′=—O—C(O)—;
n1 is 0 or 1;
U is a linear or branched C1-C20 alkylene optionally substituted with a —ONO2 group;
when Y and Y′ are selected from b), c), d), e) or e′), the —ONO2 group of -(T-Y—ONO2), -(T′-Y—ONO2), -(T″-Y′—ONO2), -(T′-Y′—ONO2), -(T′″-Y—ONO2) and -(T′″-Y′—ONO2) is linked to the (CH2)— group;
—(CH2—CH2-T2)n3-CH2—CH2— f)
wherein T2 is —O— or —S—, —NH— and n3 is an integer from 1 to 6;
wherein:
n4 is an integer from 0 to 10;
n5 is an integer from 1 to 10;
R14, R15, R16, R17 are the same or different, and are H or straight or branched C1-C4 alkyl;
wherein the —ONO2 group is linked to
wherein n5 is as defined above;
Y2 is an heterocyclic saturated, unsaturated or aromatic 5 or 6 members ring, containing one or more heteroatoms selected from nitrogen, oxygen, sulphur,
and is selected from the group consisting of:

### Claim 2 (depends on 1)

A compound of formula (I) according to claim 1 wherein R, R1, R2, R3 and R4 are as defined in claim 1;
a is 0 and
Rx is selected from:
—C(O)—CH(R1)—NH-(T′-Y—ONO2) (a2)
wherein
R1 of the group A1) is selected from H, isobutyl, benzyl, C6H5—CH2—CH2—, 2-monosubstituted benzyl, or 3-monosubstituted benzyl or 4-monosubstituted benzyl wherein the substituent of the benzyl is selected from —F, —Cl, —I, —NO2, —CF3, —CH3, CN, C6H5CO—;
R1 of the group A2) is selected from —CH2—OH, —CH(CH3)OH— or —CH2[(C6H4)-(4-OH)], or
R1 of the group A3) is selected from —CH2—NHR″, —(CH2)2—NHR″, —(CH2)3—NHR″, —(CH2)4—NHR″, wherein R″ is H, or —C(O)CH3;
R1 of the group A4) is selected from —CH2—C(O)R′″, —(CH2)2—C(O)R′″, —(CH2)4—C(O)R′″ wherein R′″ is OR5a wherein R5a is H or a linear (C1-C5) alkyl;
T′ is —C(O)—, —C(O)—X″ wherein X″ is —S— or —O—;
or Rx is
—C(O)—CH(R1a-T″-Y′—ONO2)—NHR4a (a4)
wherein R1a of the group A5) is selected from —CH2—O—, —CH(CH3)O— or —CH2[(C6H4)-(4-O)—], or
R1a of the group A6) is selected from —CH2—NH—, —(CH2)2—NH—, —(CH2)3—NH—, —(CH2)4—NH—, or
R1a of the group A7) is selected from —CH2—C(O)—, —(CH2)2—C(O)—, —(CH2)4—C(O)—;
R4a is H or —C(O)CH3;
T″ is C(O)— or —C(O)—X″ wherein X″ is —S— or —O—, when R1a is selected from the group A5) or A6);
T″ is —O—, —S—, —NR′— or O—CH(R′)—O—C(O)— wherein R′ is H or CH3, when R1a is selected from the group A7);
or Rx is selected from
—R1b—CH(NHR4a)—C(O)-(T-Y—ONO2) (a5)
—R1b—CH(COOR3a)NH-(T′-Y—ONO2) (a6)
—R1b—CH(NH-T′-Y′—ONO2)—C(O)-(T-Y—ONO2) or (a9)
—R1b—CH(C(O)-T-Y′—ONO2)—NH-(T′-Y—ONO2) (a10)
wherein
R1b of the group A10) is selected from —C(O)—CH2—, —C(O)—(CH2)2—, —C(O)—(CH2)4—;
R3a is H or a (C1-C5) alkyl;
R4a is H or —C(O)CH3;
T is —O—, —S—, —NR′— or —O—CH(R′)—O—C(O)— wherein R′ is H or CH3;
T′ is C(O)— or —C(O)—X″ wherein X″ is —S— or —O—;
or Rx is
—C(O)—CH(R1a-T″-Y′—ONO2)—NH-(T′-Y—ONO2) (a8)
wherein
R1a of the group A5) is selected from CH2—O—, —CH(CH3)—O— or CH2[(C6H4)-(4-O)], or
R1a of the group A6) is selected from —CH2—NH—, —(CH2)2—NH—, —(CH2)3—NH—, —(CH2)4—NH—, or
R1a of the group A7) is selected from —CH2—C(O)—, —(CH2)2—C(O)—, —(CH2)4—C(O)—;
T″ is C(O)— or —C(O)—X″ wherein X″ is —S— or —O—, when R1a is selected from the group A5) or A6)-;
T″ is —O—, —S—, —NR′— or —O—CH(R′)—O—C(O)— wherein R′ is H or CH3, when R1a is selected from the group A7);
T′ is C(O)— or —C(O)—X″ wherein X″ is —S— or —O—;
or Rx is
—C(O)—CH2—CH(R2)—NH-(T′-Y—ONO2) (b2)
wherein
R2 of the group B1) is selected from H, CH3, isobutyl, isopropyl, benzyl;
T′ is —C(O)—, —C(O)—X″ wherein X″ is —S— or —O—;
Y and Y′ are each independently selected from
a)
a straight or branched C1-C10 alkylene,
a straight or branched C1-C10 alkylene substituted with a —ONO2 group;
wherein:
n2 is an integer from 0 to 2, R13 is H or CH3, T1 is —O—C(O)— or —C(O)O—;
n1 is 1 and U is a linear C1-C10 alkylene or U is a linear or branched C1-C10 alkylene substituted with a —ONO2 group;
n2 is 1, R13 is CH3, Y1 is CH═CH—(CH2)n2′ and n7 is 0, T1 is C(O)O— and U is a linear C1-C10 alkylene;
wherein:
n2 is 1, R13 is CH3;
Y1 is (CH2)n2′—CH═CH— and n2′ is 0;
(T1)′=—O—C(O)—;
n1 is 1 and U is a linear C1-C10 alkylene or U is a linear or branched C1-C10 alkylene substituted with a —ONO2 group;
when Y and Y′ are selected from d), e) or e′), the —ONO2 group of -(T-Y—ONO2), -(T′-Y—ONO2), -(T″-Y′—ONO2), -(T′-Y′—ONO2), -(T′″-Y—ONO2) and -(T′″-Y′—ONO2) is linked to the (CH2)— group;
—(CH2—CH2-T2)n3—CH2—CH2— f)
wherein T2 is —O— or —S—, —NH—, n3 is 1 or 2.

### Claim 3 (depends on 1)

A compound of formula (I) according to claim 1 wherein R, R1, R2, R3 and R4 are as defined in claim 1,
A is 1 and Z is C(O)—,
Rx is
—HN—CH(R1)—C(O)-(T-Y—ONO2) (a1)
wherein
R1 of the group A1) is selected from H, isobutyl, benzyl, C6H5—CH2—CH2—, 2-monosubstituted benzyl, or 3-monosubstituted benzyl or 4-monosubstituted benzyl wherein the substituent of the benzyl is selected from F, —Cl, —I, —NO2, —CF3, —CH3, CN, C6H5CO—;
or
R1 of A2) is selected from CH2—OH, —CH(CH3)—OH— or —CH2[(C6H4)-(4-OH)], or
R1 of the group A3) is selected from —CH2—NHR″, —(CH2)2—NHR″, —(CH2)3—NHR″, —(CH2)4—NHR″, wherein R″ is H, or C(O)CH3,
R1 of the group A4) is —CH2—C(O)R′″, —(CH2)2—C(O)R′″, —(CH2)4—C(O)R′″ wherein R′″ is OR5a wherein R5a is H or a linear (C1-C5) alkyl;
T is —O—, —S—, —NR′—, O—CH(R′)—O—C(O)— wherein R′ is H or a straight or branched C1-C4 alkyl;
Y is as below defined;
or Rx is
—HN—CH(R1a-T′″-Y′—ONO2)—COOR3a (a3)
wherein
R1a of the group A5) is selected from CH2—O—, —CH(CH3)O— or CH2[(C6H4)Op-], or
R1a of the group A6) is selected from —CH2—NH—, —(CH2)2—NH—, —(CH2)3—NH—, —(CH2)4—NH—, or
R1a of the group A7) is —CH2—C(O)—, —(CH2)2—C(O)—, —(CH2)4—C(O)—;
R3a is H or a (C1-C5) alkyl;
T″ is C(O)— or —C(O)—X″ wherein X″ is —S— or —O—, when R1a is selected from the group A5) or A6);
T″ is —O—, —S—, —NR′—, O—CH(R′)—O—C(O)— wherein R′ is H or a straight or branched C1-C4 alkyl, when R1a is selected from the group A7);
Y′ is as below defined;
or Rx is
—R1b—CH(NHR4a)—C(O)-(T-Y—ONO2) (a5)
—R1b—CH(COOR3a)NH-(T′-Y—ONO2) (a6)
—R1b—CH(NH-T′-Y′—ONO2)—C(O)-(T-Y—ONO2) or (a9)
—R1b—CH(C(O)-T-Y′—ONO2)—NH-(T′-Y—ONO2) (a10)
wherein
R1b of the group A8) is selected from —O—CH(CH3)—, —O—CH2—, [-4-O)—(C6H4)]—CH2—, or
R1b of the group A9) is selected from —HN—CH2—, —HN—(CH2)2—, —HN—(CH2)3—, —HN—(CH2)4—;
R3a is H or a (C1-C5) alkyl;
R4a is H or C(O)CH3;
T is —O—, —S—, —NR′—, —O—CH(R′)—O—C(O)— wherein R′ is H or a straight or branched C1-C4 alkyl;
T′ is C(O)— or —C(O)—X″ wherein X″ is —S— or —O—;
Y and Y′ are as below defined;
or Rx is
—HN—CH(R1a-T″-Y′—ONO2)—C(O)-(T-Y—ONO2) (a7)
wherein
R1a of the group A5) is selected from CH2—O—, —CH(CH3)—O— or CH2[(C6H4)-(4-O)—], or
R1a of the group A6) is selected from —CH2—NH—, —(CH2)2—NH—, —(CH2)3—NH—, —(CH2)4—NH—, or
R1a of the group A7) is —CH2—C(O)—, —(CH2)2—C(O)—, —(CH2)4—C(O)—;
T″ is C(O)— or —C(O)—X″ wherein X″ is —S— or —O—;
T″ is —O—, —S—, —NR′—, —O—CH(R′)—O—C(O)— wherein R′ is H or a straight or branched C1-C4 alkyl, when R1a is selected from A7);
T is —O—, —S—, —NR′—, —O—CH(R′)—O—C(O)— wherein R′ is H or a straight or branched C1-C4 alkyl;
Y and Y′ are as below defined;
or Rx is
—HN—CH(R2)—CH2C(O)-(T-Y—ONO2) (b1)
wherein
R2 of the group B1) is selected from H, CH3, isobutyl, isopropyl, benzyl;
R2 of the group B2) is selected from CH2—OH, —CH(CH3)—OH— or CH2[(C6H4)(4-OH)], or
R2 of the group B3) is selected from —CH2—NHR″, —(CH2)2—NHR″, —(CH2)3—NHR″, —(CH2)4—NHR″, wherein R″ is H, or C(O)CH3,
R2 of the group B4) is —CH2—C(O)R′″, —(CH2)2—C(O)R′″, —(CH2)4—C(O)R′″ wherein R′″ is OR5a
wherein R5a is H or a linear (C1-C5) alkyl;
T is —O—, —S—, —NR′—, —O—CH(R′)—O—C(O)— wherein R′ is H or a straight or branched C1-C4 alkyl;
Y is as below defined;
or Rx is selected from
—HN—CH(R12)—CH2—O-(T′″-Y—ONO2) (d1)
—O—CH2—CH(R12)—NH-(T′-Y—ONO2) (d2)
wherein
R12 of the group D1) is selected from H, CH3, isobutyl, isopropyl, benzyl, or
R12 of the group D2) is selected from CH2—OH, —CH(CH3)OH— or CH2[)C6H4)-(4-OH)], or
R12 of the group D3) is selected from —CH2—NHR″, —(CH2)2—NHR″, —(CH2)3—NHR″, —(CH2)4—NHR″ wherein R″ is H, or
R12 of the group D4) is —CH2—C(O)R′″, —(CH2)2—C(O)R′″, —(CH2)4—C(O)R′″ wherein R′″ is OR5a
wherein R5a is H or a linear (C1-C5) alkyl;
T′ and T′″ are each independently selected from C(O)— or —C(O)—X″ wherein X″ is —S— or —O—;
Y is as below defined;
or Rx is selected from
—HN—CH(R12a-T″-Y′—ONO2)—CH2OH (d3)
—O—CH2—CH(R12a-T″-Y′—ONO2)—NHR4a (d4)
—HN—CH(R12a-T″-Y′—ONO2)—CH2—O-(T′″-Y—ONO2) or (d7)
—O—CH2—CH(R12a-T″-Y′—ONO2)—NH-(T′-Y—ONO2) (d8)
wherein
R12a of the group D5) is selected from CH2—O—, —CH(CH3)—O— or CH2[(C6H4)-(4-O)—], or
R12a of the group D6) is selected from —CH2—NH—, —(CH2)2—NH—, —(CH2)3—NH—, —(CH2)4—NH—, or
R12a of the group D7) is —CH2—C(O)—, —(CH2)2—C(O)—, —(CH2)4—C(O)—;
R4a is H or —C(O)CH3;
T″ is selected from C(O)— or —C(O)—X″ wherein X″ is —S— or —O—;
T″ is —O—, —S—, —NR′—, —O—CH(R′)—O—C(O)— wherein R′ is H or a straight or branched C1-C4 alkyl;
T′″ is selected from C(O)— or —C(O)—X″ wherein X″ is —S— or —O—;
Y and Y′ are as below defined;
or Rx is selected from
—R12b—CH(NHR4a)—CH2—O-(T′″-Y—ONO2) (d5)
—R12b—CH(CH2OH)—NH-(T′-Y—ONO2) (d6)
—R12b—CH(NH-T′-Y′—ONO2)—CH2—O-(T′″-Y—ONO2) or (d9)
—R12b—CH(CH2—O-T′″-Y′—ONO2)—NH-(T′-Y—ONO2) (d10)
wherein
R12b of the group D8) is selected from —O—CH(CH3)—, —O—CH2—, [—Op(C6H4)]—CH2—, or
R12b of the group D9) is selected from —HN—CH2—, —HN—(CH2)2—, —HN—(CH2)3—, —HN—(CH2)4—;
R4a is H or —C(O)—CH3,
T′ and T′″ are each independently selected from —C(O)—, —C(O)—X″, wherein X″ is —S— or —O—;
Y and Y′ are each independently selected from
a)
a straight or branched C1-C10 alkylene,
a straight or branched C1-C10 alkylene substituted with a —ONO2 group;
wherein:
n2 is an integer from 0 to 2, R13 is H or CH3, T1 is —O—C(O)— or C(O)O—;
n1 is 1 and U is a linear C1-C10 alkylene or U is a linear or branched C1-C10 alkylene substituted with a —ONO2 group;
n2 is 1, R13 is CH3, Y1 is CH═CH—(CH2)n2′- and n7 is 0, T1 is C(O)O— and U is a linear C1-C10 alkylene;
wherein:
n2 is 1, R13 is CH3;
Y1 is (CH2)n2′—CH═CH— and n2′ is 0;
(T1)′=—O—C(O)—;
n1 is 1 and U is a linear C1-C10 alkylene or U is a linear or branched C1-C10 alkylene substituted with a —ONO2 group;
when Y and Y′ are selected from d), e) or e′), the —ONO2 group of -(T-Y—ONO2), -(T′-Y—ONO2), -(T″-Y′—ONO2), -(T′-Y′—ONO2), -(T′″-Y—ONO2) and -(T′″Y′—ONO2) is linked to the (CH2)— group;
—(CH2—CH2-T2)n3—CH2—CH2— f)
wherein T2 is —O— or —S—, —NH—, n3 is 1 or 2.

### Claim 4

(canceled)

### Claim 5 (depends on 1)

A compound of formula (I) according to claim 1 wherein
R, R1, R2, R3, and R4 are as defined in claim 1;
A is 0;
Rx is
—R1b—CH(NHR4a)—C(O)-(T-Y—ONO2) or (a5)
—R1b—CH(NH-T′-Y′—ONO2)—C(O)-(T-Y—ONO2) (a9)
wherein
R1b is C(O)—CH2—,
R4a is H or C(O)CH3;
T is selected from O—, —S—, —NR′— wherein R′ is as above defined,
T′ is C(O)— and
Y and Y′ are each independently selected from
a)
a straight or branched C1-C10 alkylene,
a straight or branched C1-C10 alkylene substituted with a —ONO2 group;
wherein:
n2 is an integer from 0 to 2, R13 is H or CH3, T1 is —O—C(O)— or C(O)O—;
n1 is 1 and U is a linear C1-C10 alkylene or U is a linear or branched C1-C10 alkylene substituted with a —ONO2 group;
n2 is 1, R13 is CH3, Y1 is CH═CH—(CH2)n2′- and n7 is 0, T1 is C(O)O— and U is a linear C1-C10 alkylene;
wherein:
n2 is 1, R13 is CH3;
Y1 is (CH2)n2′—CH═CH— and n2′ is 0;
T1)′=—O—C(O)—;
n1 is 1 and U is a linear C1-C10 alkylene or U is a linear or branched C1-C10 alkylene substituted with a —ONO2 group;
when Y and Y′ are selected from d), e) or e′), the —ONO2 group of -(T-Y—ONO2), -(T′-Y—ONO2), -(T″-Y′—ONO2), -(T′-Y′—ONO2), -(T′″-Y—ONO2) and -(T′″-Y′—ONO2) is linked to the (CH2)— group;
—(CH2—CH2-T2)n3—CH2—CH2— f)
wherein T2 is —O— or —S—, —NH—, n3 is 1 or 2;

### Claim 6 (depends on 1)

A compound of formula (I) according to claim 1 wherein R, R1, R2, R3 and R4 are as defined in claim 1;
A is 1 and Z is C(O)—,
Rx is
—R1b—CH(NHR4a)—C(O)-(T-Y—ONO2) or (a5)
—R1b—CH(NH-T′-Y′—ONO2)—C(O)-(T-Y—ONO2) (a9)
wherein R1b of A10) is —O—CH2— or [—Op—(C6H4)]—CH2—,
R4a is H or C(O)CH3,
T is selected from O—, —S—, —NR′— wherein R′ is as above defined,
T′ is C(O)— and
Y and Y′ are each independently selected from
a)
a straight or branched C1-C10 alkylene,
a straight or branched C1-C10 alkylene substituted with a —ONO2 group;
wherein:
n2 is an integer from 0 to 2, R13 is H or CH3, T1 is —O—C(O)— or C(O)O—;
n1 is 1 and U is a linear C1-C10 alkylene or U is a linear or branched C1-C10 alkylene substituted with a —ONO2 group;
n2 is 1, R13 is CH3, Y1 is —CH═CH—(CH2)n2′— and n2′ is 0, T1 is C(O)O— and U is a linear C1-C10 alkylene;
wherein:
n2 is 1, R13 is CH3;
Y1 is (CH2)n2′—CH═CH— and n2′ is 0;
(T1)′=—O—C(O)—;
n1 is 1 and U is a linear C1-C10 alkylene or U is a linear or branched C1-C10 alkylene substituted with a —ONO2 group;
when Y and Y′ are selected from d), e) or e′), the —ONO2 group of -(T-Y—ONO2), -(T′-Y—ONO2), -(T″-Y′—ONO2), -(T′-Y′—ONO2), -(T′″-Y—ONO2) and -(T′″-Y′—ONO2) is linked to the (CH2)— group;
—(CH2—CH2-T2)n3—CH2—CH2— f)
wherein T2 is —O— or —S—, —NH—, n3 is 1 or 2.

### Claim 7 (depends on 1)

A compound of formula (I) according to claim 1 wherein R, R1, R2, R3 and R4 are as defined in claim 1;
A is 0,
Rx is
—C(O)—CH2—CH(R2)—NH-(T′-Y—ONO2) (b2)
wherein
R2 is H,
T′ is C(O)—;
Y and Y′ are each independently selected from
a)
a straight or branched C1-C10 alkylene,
a straight or branched C1-C10 alkylene substituted with a —ONO2 group;
wherein:
n2 is an integer from 0 to 2, R13 is H or CH3, T1 is —O—C(O)— or C(O)O—;
n1 is 1 and U is a linear C1-C10 alkylene or U is a linear or branched C1-C10 alkylene substituted with a —ONO2 group;
n2 is 1, R13 is CH3, Y1 is CH═CH—(CH2)n2′- and n7 is 0, T1 is C(O)O— and U is a linear C1-C10 alkylene;
wherein:
n2 is 1, R13 is CH3;
Y1 is (CH2)n2′—CH═CH— and n2′ is 0;
(T1)′=—O—C(O)—;
n1 is 1 and U is a linear C1-C10 alkylene or U is a linear or branched C1-C10 alkylene substituted with a —ONO2 group;
when Y and Y′ are selected from d), e) or e′), the —ONO2 group of -(T-Y—ONO2), -(T′-Y—ONO2), -(T″-Y′—ONO2), -(T′-Y′—ONO2), -(T′″-Y—ONO2) and -(T′∝1-Y′—ONO2) is linked to the (CH2)— group;
—(CH2—CH2-T2)n3—CH2—CH2— f)
wherein T2 is —O— or —S—, —NH— n3 is 1 or 2.

### Claim 8

(canceled)

### Claim 9

(canceled)

### Claim 10 (depends on 1)

A compound of formula (I) according to claim 1 for use in the treatment of ocular diseases.

### Claim 11

(canceled)

### Claim 12 (depends on 1)

A compound of formula (I) according to claim 1 for use in the treatment of respiratory diseases.

### Claim 13

(canceled)

### Claim 14 (depends on 1)

A compound of formula (I) according to claim 1 for use in the treatment of dermatological diseases.

### Claim 15

(canceled)

### Claim 16

(canceled)
